
    
      This therapy involves the use of melphalan, etoposide, and carboplatin (consolidation
      chemotherapy); autologous stem cell rescue, post-transplant radiation therapy and a
      maintenance phase with Isotretinoin (Accutane, 13-cis-retinoic acid) therapy. If available,
      patients should also consider post-transplant therapy with cytokines and monoclonal antibody
      (ch14.18) on a COG or New Approaches to Neuroblastoma Therapy (NANT) trial.
    
  